enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. New schizophrenia drug gets FDA approval, taking novel ... - AOL

   www.aol.com/news/schizophrenia-drug-gets-fda...

   September 27, 2024 at 2:25 PM. New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder. A new drug has been approved for the treatment of schizophrenia in adults ...

3. This FDA-approved drug promises a new way to treat schizophrenia

   www.aol.com/fda-approved-drug-promises-way...

   Updated September 29, 2024 at 12:48 PM. People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday ...

4. Bristol Myers wins US FDA approval for new type of ...

   www.aol.com/news/us-fda-approves-bristol-myers...

   September 27, 2024 at 6:06 AM. By Bhanvi Satija and Michael Erman. (Reuters) -The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it ...

5. Xanomeline/trospium chloride - Wikipedia

   en.wikipedia.org/wiki/Xanomeline/trospium_chloride

   The effectiveness of xanomeline/trospium chloride for the treatment of schizophrenia in adults was evaluated in two studies with identical designs. [2] Study 1 (NCT04659161) and study 2 (NCT04738123) were 5-week, randomized, double-blind, placebo-controlled, multi-center studies in adults with a diagnosis of schizophrenia according to DSM-5 ...

6. Ulotaront - Wikipedia

   en.wikipedia.org/wiki/Ulotaront

   Ulotaront (INN; [1] developmental codes SEP-363856, SEP-856) is an investigational antipsychotic that is undergoing clinical trials for the treatment of schizophrenia and Parkinson's disease psychosis. [2][3] The medication was discovered in collaboration between PsychoGenics Inc. and Sunovion Pharmaceuticals [2] (which was subsequently merged ...

7. Brilaroxazine - Wikipedia

   en.wikipedia.org/wiki/Brilaroxazine

   Brilaroxazine. Brilaroxazine (developmental code name RP5063), also known as oxaripiprazole, [1][2] is an investigational atypical antipsychotic which is under development by Reviva Pharmaceuticals for the treatment of neuropsychiatric and inflammatory disorders. [3][5][6][7] It has currently completed the first of two phase III clinical trials ...

8. FDA approves 1st new drug for schizophrenia in more ... - AOL

   www.aol.com/fda-approves-1st-drug-schizophrenia...

   Loaded 0%. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers ...

9. Lumateperone - Wikipedia

   en.wikipedia.org/wiki/Lumateperone

   Lumateperone. Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the butyrophenone class. It is approved for the treatment of schizophrenia as well as bipolar depression, as either monotherapy or adjunctive therapy (with lithium or valproate). [ 2 ] It is developed by Intra-Cellular Therapies, licensed ...